Nomogram-Integrated C-Reactive Protein/Albumin Ratio Predicts Efficacy And Prognosis In Patients With Thoracic Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2 ):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol. 2001;30(6 ):1415–1425. doi:10.1093/ije/30.6.141511821356
   PubMed Web of Science ®Google Scholar
• Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19(34 ):5598–5606. doi:10.3748/wjg.v19.i34.559824039351
   PubMed Web of Science ®Google Scholar
• Rice TW, Rusch VW, Ishwaran H, Blackstone EH, Worldwide Esophageal Cancer Collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116(16 ):3763–3773. doi:10.1002/cncr.2514620564099
   PubMed Web of Science ®Google Scholar
• Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (jcog9907). Ann Surg Oncol. 2012;19(1 ):68–74. doi:10.1245/s10434-011-2049-921879261
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255 ):539–545. doi:10.1016/S0140-6736(00)04046-011229684
   PubMed Web of Science ®Google Scholar
• Sato H, Tsubosa Y, Kawano T. Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg. 2012;36:617–622. doi:10.1007/s00268-011-1411-122223293
   PubMed Web of Science ®Google Scholar
• Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014;12:58. doi:10.1186/1477-7819-12-5824641770
   PubMed Web of Science ®Google Scholar
• Matsuda S, Takeuchi H, Kawakubo H, et al. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol. 2015;22(1 ):302–310. doi:10.1245/s10434-014-3857-524952029
   PubMed Web of Science ®Google Scholar
• Kimura J, Kunisaki C, Makino H, et al. Evaluation of the Glasgow prognostic score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer. Dis Esophagus. 2016;29(8 ):1071–1080. doi:10.1111/dote.1242026471766
   PubMed Web of Science ®Google Scholar
• Hirashima K, Watanabe M, Shigaki H, et al. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol. 2014;49(6 ):1040–1046. doi:10.1007/s00535-013-0855-523821018
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Tanaka K, Nojiri K, et al. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2014;21(5 ):1711–1718. doi:10.1245/s10434-013-3342-624452408
   PubMed Web of Science ®Google Scholar
• Liu X, Sun X, Liu J, et al. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4 ):339–345. doi:10.1016/j.tranon.2015.06.00626310380
   PubMed Web of Science ®Google Scholar
• Tao CJ, Chen YY, Jiang F, et al. The C-reactive protein/albumin ratio is an independent prognostic factor for overall survival in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy. J Cancer. 2016;7(14 ):2005–2011. doi:10.7150/jca.1621027877215
   PubMed Web of Science ®Google Scholar
• Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6 ):1471–1474. doi:10.1245/s10434-010-0985-420180029
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2 ):228–247. doi:10.1016/j.ejca.2008.10.02619097774
   PubMed Web of Science ®Google Scholar
• McNamara MG, Templeton AJ, Maganti M, et al. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer. Eur J Cancer. 2014;50(9 ):1581–1589. doi:10.1016/j.ejca.2014.02.01524630393
   PubMed Web of Science ®Google Scholar
• Mohammed ZM, Going JJ, Edwards J, et al. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2012;107(5 ):864–873. doi:10.1038/bjc.2012.34722878371
   PubMed Web of Science ®Google Scholar
• Thurner EM, Krenn–Pilko S, Langsenlehner U, et al. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Eur J Cancer. 2015;51(5 ):610–619. doi:10.1016/j.ejca.2015.01.00225618827
   PubMed Web of Science ®Google Scholar
• Szkandera J, Stotz M, Absenger G, et al. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014;110(1 ):183–188. doi:10.1038/bjc.2013.70124201751
   PubMed Web of Science ®Google Scholar
• Kijima T, Arigami T, Uchikado Y, et al. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma. Cancer Sci. 2017;108(2 ):193–199. doi:10.1111/cas.1312727889946
   PubMed Web of Science ®Google Scholar
• Cho IR, Park JC, Park CH, et al. Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014;17(4 ):703–710. doi:10.1007/s10120-013-0330-224442663
   PubMed Web of Science ®Google Scholar
• Zhu S, Miao CW, Wang ZT, Peng L, Li B. Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma. Onco Targets Ther. 2016;9:6187–6193. doi:10.2147/OTT.S11501127789959
   PubMed Web of Science ®Google Scholar
• Chua W, Charles KA, Baracos VE, Clarke SJ. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer. 2011;104:1288–1295. doi:10.1038/bjc.2011.10021448173
   PubMed Web of Science ®Google Scholar
• Sun W, Zhang L, Luo M, et al. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Head Neck. 2016;38(Suppl 1 ):E1332–E1340. doi:10.1002/hed.2422426362911
   PubMedGoogle Scholar
• Zhang W, Liu K, Ye B, Liang W, Ren Y. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer. Cancer Med. 2018;7:105–113. doi:10.1002/cam4.127029193777
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen S, Zheng C, et al. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. BMC Cancer. 2017;17:285. doi:10.1186/s12885-017-3220-x28431566
   PubMed Web of Science ®Google Scholar